Preparation method and application of simulated human body lubricating liquid

By combining the liquid film and boundary lubrication mechanism in the simulated human lubricant and adding HIV prevention components, the problems of low lubrication aging and poor compatibility with latex surface are solved, and efficient lubrication and HIV prevention effects are achieved. Reduces the risk of viral transmission in sexual behavior.

CN118987370APending Publication Date: 2024-11-22ZHENGHE BEIMIAO TRADING CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411093269.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art is difficult to effectively prevent the transmission of sexually transmitted diseases such as HIV, especially in sexual behaviors. The lubricating age of existing lubricants is low and has poor compatibility with latex surfaces, making it difficult to provide long-term lubricating and preventive effects. .

Method used

A method of preparing a simulated human lubricant, including core-shell liposomes, penetration enhancers, hyaluronic acid, thickeners, moisturizing agents, pH regulators, antioxidants, antibacterial agents and preservatives, through the binding liquid The mechanism of membrane lubrication and boundary lubrication is used to form an efficient lubricating film, and the addition of tenofovir fumarate dipyroxate to the lubricant to prevent HIV virus.

Benefits of technology

It improves the wetting and repairing ability of lubricants, enhances the moisturizing effect on the human cavity mucosa, and also has the function of preventing HIV, reduces the risk of virus transmission during sexual behavior, and provides longer-term lubrication and protection effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004987164290000131
    Figure BDA0004987164290000131
  • Figure BDA0004987164290000141
    Figure BDA0004987164290000141
Patent Text Reader

Abstract

The invention discloses a preparation method and application of simulated human body lubricating liquid, and relates to the technical field of medical protection and family planning supplies. Preparing the HIV prevention core-shell liposome by adopting a film hydration method; the preparation method comprises the following steps: adding a half of the required amount of thickening agent into deionized water, slowly adding hyaluronic acid into pure water while heating and stirring, fully dissolving, adding the HIV prevention core-shell liposome, the penetration enhancer, the humectant, the antioxidant, the bacteriostatic agent and the preservative, homogenizing, reducing the rotating speed, slowly adding a half of the required amount of thickening agent, homogenizing, cooling to room temperature, and packaging. And adjusting the pH value to 6.5-7.5 to prepare the simulated human body lubricating liquid. The lubricating action mechanism is between liquid film lubrication and boundary lubrication, and the prepared simulated human body lubricating liquid has good biocompatibility and lubricating and moisturizing performance, can moisten and hydrate human body cavity mucous membranes, can be used as a lubricant for heterosexual or isosexual behaviors, and can be used for preventing and dosing vagina or rectum in advance to reduce the HIV risk.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medical protection and family planning products, and in particular to a preparation method and application of simulated human body lubricating liquid. Background Art

[0002] Lubrication is an essential component of biological systems because it enables various parts of the body to move and function smoothly. Without lubrication, the body may experience inflammation, pain, and dysfunction. Current knowledge suggests that lubrication in the body is achieved through a combination of physical fluid flow and chemical biomacromolecule mechanisms. Physical fluid flow refers to synovial fluid in joints, mucus in the respiratory and digestive tracts, and vaginal secretions in women. Chemical biomacromolecules include carbohydrates, proteins, and lipids, which cover the surfaces of cells and tissues to reduce friction. In general, the human body produces several types of lubricating fluids and lubricating biomacromolecules to help facilitate movement and reduce friction.

[0003] Fluid film lubrication is a lubrication model in which the load is supported entirely by the lubricant through viscous forces in the space or gap between the parts moving relative to one another, thereby avoiding solid-to-solid contact. In hydrostatic lubrication, external pressure is applied to the lubricant in the bearing to maintain a fluid lubricating film, otherwise it would be squeezed out.

[0004] Boundary lubrication is defined as a regime in which the load is carried by surface high points rather than by the lubricant. Under high pressure conditions, the chemical composition of the lubricant interacts with the contacting tissue surface to form a highly resistive boundary layer or film on the moving solid surface that supports the load and avoids significant wear. For this reason, the focus of recent research has shifted from using fluid film-based models to the properties of molecular boundary layers on tissue surfaces.

[0005] As of 2023, the Joint United Nations Programme on HIV / AIDS estimates that 39.9 million people worldwide are living with HIV, with sexual transmission being the leading cause of new infections. Although considerable progress has been made since the introduction of antiretroviral-based therapies, HIV has become a growing global health problem, requiring new prevention strategies to combat and control the spread of the virus as early as possible. Summary of the invention

[0006] The purpose of the present invention is to provide a method for preparing a simulated human body lubricating fluid and its application, so as to solve the problems raised in the background technology.

[0007] To achieve the above object, the present invention provides the following technical solutions:

[0008] A method for preparing a simulated human body lubricating fluid, comprising the following raw materials in percentage by mass:

[0009] Core-shell liposome: 0.05-0.5%;

[0010] Penetration enhancer 0.8-5%;

[0011] Hyaluronic acid 0.05-0.1%;

[0012] Thickener 8-12%;

[0013] Moisturizer 0.1-0.5%;

[0014] pH adjuster 0.1-3%;

[0015] Antioxidants 0.01-0.05%;

[0016] Antibacterial agent 0.1-0.5%;

[0017] Preservatives 0.05-0.25%;

[0018] The balance is deionized water;

[0019] The preparation method specifically comprises the following steps:

[0020] Add half of the required amount of thickener to deionized water, heat it to 25-35°C, slowly add hyaluronic acid to pure water while stirring at a speed of 800-1200r / min until sodium hyaluronate is fully dissolved, add core-shell liposomes, penetration enhancers, moisturizers, antioxidants, antibacterial agents and preservatives, homogenize for 30 minutes, maintain the temperature, reduce the speed to 300-600r / min, slowly add half of the required amount of thickener, homogenize for 10 minutes, cool naturally to room temperature, and adjust the pH to 6.5-7.5 with a pH adjuster to obtain a simulated human body lubricating fluid;

[0021] It should be noted that water-based lubricants have good affinity with the skin and cavity mucosa, and can form a good flow lubrication layer, but have poor compatibility with the latex surface, and the bonding force between the adsorbed lubricating film and the latex surface is weak, which leads to the generally low lubrication time of water-based lubricants. As described in the background technology, according to the state and properties of the lubricating film layer formed by the lubricant during friction, lubrication can be divided into liquid film lubrication and boundary lubrication. Therefore, the present invention incorporates liposomes and penetration enhancers on the basis of aqueous lubricating fluids, so that the lubrication mechanism of the present invention is between liquid film lubrication and boundary lubrication, wherein the lubricating film generated is not sufficient to completely separate the contact surface, but the fluid dynamic effect is quite large. In addition to supporting the load, the lubricant may also have to perform other functions, such as removing wear debris. When performing these functions, the lubricant will be continuously removed from the contact surface by relative motion or external induced force.

[0022] Furthermore, the preparation steps of the core-shell liposome are as follows:

[0023] Dioleoylphosphatidylcholine, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine, distearoylphosphatidylcholine and cholesterol were dissolved in chloroform, and the organic solvent was evaporated under a constant nitrogen flow at 37°C to obtain a dry lipid film. An aqueous solution of tenofovir disoproxil fumarate was added at 45-65°C, and the mixture was centrifuged at 300 r / min for 30 min. The dispersion was sequentially extruded and filtered through 0.8 μm, 0.4 μm, 0.2 μm, and 0.1 μm polycarbonate membrane filters for 4 times each to obtain core-shell liposomes.

[0024] It should be noted that dioleoylphosphatidylcholine, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine and distearoylphosphatidylcholine are all zwitterionic liposomes with an oven temperature of 41-64°C. The selected liposomes have no cytotoxicity to human endometrial adenocarcinoma cells and human cervical cancer intestinal metastatic cells, and can promote the transmembrane permeation of tenofovir disoproxil fumarate.

[0025] Furthermore, in the preparation step of the core-shell liposome, the dosage ratio of dioleoylphosphatidylcholine, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine, distearoylphosphatidylcholine, cholesterol and tenofovir disoproxil fumarate aqueous solution is (0-5.5) mg: (0-5.5) mg: (0-5.5) mg: (0-5.5) mg: (3-4) mg: 20 mL; the concentration of the tenofovir disoproxil fumarate aqueous solution is 40-120 μM / mL.

[0026] It should be noted that tenofovir disoproxil fumarate is a prodrug of the nucleotide reverse transcriptase inhibitor tenofovir. When it acts on the vagina, it can prevent HIV virus and work in the early stages of infection, that is, it works on the cervical vaginal mucosa. The absorption of core-shell liposomes is mainly through passive diffusion through the lipid channels of the cell membrane through the vaginal mucosa, and there is little degradation of enzymes in the vagina. The drug absorption directly enters the systemic circulation, avoiding the first-pass effect and improving bioavailability. When it acts on the rectum, it can play an early preventive role at the lipid channels of the rectal wall cells and the entrance of the sigmoid colon. The absorption of core-shell liposomes by the rectum is also mainly based on the lipid channels of the cell membrane. Tenofovir disoproxil fumarate is well distributed in the lipid bilayer and does not interfere with the biophysical stability of the liposome. The reason why tenofovir was not directly selected is that tenofovir can produce strong biophysical damage to the polar head groups of the lipid bilayer, and liposomes are not suitable carriers for tenofovir. Therefore, tenofovir disoproxil fumarate was finally selected to be loaded into liposomes and further incorporated into aqueous lubricating fluid.

[0027] Furthermore, the penetration enhancer is one of propylene glycol, glycerol and polyethylene glycol.

[0028] It should be noted that liposomes are deformable vesicles with the advantages of being non-toxic, having good biocompatibility, and slowing down the enzymatic hydrolysis rate of the encapsulated material. The phospholipid bilayers that constitute liposomes have structural commonalities with the cell membrane, which allows the vesicles to be absorbed by the lipid channels of the cell membrane. Permeation enhancers have similar properties to edge activators. Edge activators are usually single-chain surfactants with a large radius of curvature. Once inserted between the phospholipid bilayers, they will interfere with the bilayer structure. Edge activators have the characteristics of non-random distribution in the phospholipid bilayers. When liposomes are subjected to anisotropic forces, they will accumulate at points with higher pressure. Due to the discontinuity caused by the combination of edge activators and phospholipid bilayers, liposomes become elastic and can be deformed during the transdermal process, which can provide greater flexibility for the vesicles and enable the liposomes to be absorbed by the lipid channels of the vagina or rectum.

[0029] Furthermore, the molecular weight of the hyaluronic acid is 400,000-600,000.

[0030] It should be noted that hyaluronic acid is a mucopolysaccharide that can further improve the wetting and lubricating ability of lubricants. As a natural component existing in the human body, hyaluronic acid not only has the function of regulating osmotic pressure, but also contains a large number of carboxyl and hydroxyl groups, which can form a hydrogen bond network through intramolecular and intermolecular hydrogen bonds. It has strong moisturizing ability and certain repair ability, which can moisturize and hydrate the mucous membrane of the human cavity and further improve the degree of lubrication.

[0031] Furthermore, the thickener is one of carboxymethyl cellulose, carboxyethyl cellulose and carboxypropyl cellulose.

[0032] It should be noted that the thickener can give the human body lubricant certain non-Newtonian fluid properties, which can spread rapidly under external pressure to form a fluid lubricating layer with certain resistance to deformation between the vagina and the condom. Although it is not enough to completely separate the contact surface, the fluid dynamics effect is quite large. At the same time, its surface carboxyl groups and other polar groups can form hydrogen bonds with water, which can moisturize and hydrate the human cavity mucosa, further improving the degree of lubrication.

[0033] Furthermore, the moisturizing agent is one or more of squalane, urea, and vitamin B5.

[0034] Furthermore, the pH regulator is any one of hydrochloric acid, sulfuric acid, citric acid, sodium hydroxide, sodium bicarbonate, disodium hydrogen phosphate, and sodium dihydrogen phosphate; and the pH of the simulated human lubricating fluid is 6.5-7.5.

[0035] It should be noted that the pH of the human rectum is 7.4, and the pH of the vagina is weakly acidic. The lubricating liquid of the present invention is a neutral product and is suitable for both homosexual and heterosexual sexual behaviors.

[0036] Furthermore, the antioxidant is vitamin E; the antibacterial agent is chlorhexidine gluconate.

[0037] Furthermore, the preservative is one of sorbic acid, anisic acid, and caprylhydroxamic acid.

[0038] Furthermore, the simulated human body lubricating fluid prepared by the present invention is used in homosexual or heterosexual sexual behavior.

[0039] Compared with the prior art, the present invention has the following beneficial effects:

[0040] The lubrication mechanism of the present invention is between liquid film lubrication and boundary lubrication, wherein the lubricating film produced is not sufficient to completely separate the contact surfaces, but the fluid dynamic effect is quite large. In addition to supporting the load, the lubricant may also have to perform other functions, such as removing wear debris. While performing these functions, the lubricant is continuously removed from the contact surface through relative motion or external induced forces. The added components of the present invention can further improve the wetting ability of the lubricant, have a certain repair ability, and can produce a large number of hydrogen bonds to moisturize and hydrate the mucous membrane of the human cavity, further improving the degree of lubrication.

[0041] The core-shell liposome prepared by the present invention can prevent HIV virus and take effect in the early stage of infection. The characteristics of the liposome enable HIV prevention drugs to be absorbed by the lipid channels of the cell membrane, the selected zwitterionic liposomes have no cytotoxicity to the site of action, and the selected HIV prevention drugs are well distributed in the lipid bilayer and will not interfere with the biophysical stability of the liposomes. The penetration enhancer makes the liposomes elastic and can be deformed during the transdermal process, which can provide greater flexibility for the vesicles and enable the liposomes to be more easily absorbed by the lipid channels of the vagina or rectum.

[0042] The simulated human body lubricant prepared by the present invention has the following three characteristics at the same time: first, it has good biocompatibility, creates an isotonic human cavity environment, and restores the feeling of human body secretion liquid; second, it has excellent lubricating and moisturizing properties, moisturizes and hydrates the human cavity mucosa; third, it can be used as a lubricant for heterosexual or homosexual sexual intercourse for preventive administration to the vagina or rectum in advance, reducing the risk of HIV. DETAILED DESCRIPTION

[0043] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0044] Example 1

[0045] A simulated human body lubricating fluid, comprising the following raw materials in percentage by mass:

[0046] Core-shell liposome 0.3%;

[0047] Glycerol 3%;

[0048] Hyaluronic acid 0.08%;

[0049] Carboxymethyl cellulose 10%;

[0050] Squalane 0.3%;

[0051] Sodium hydroxide 1.5%;

[0052] Vitamin E 0.03%;

[0053] Chlorhexidine gluconate 0.3%;

[0054] Sorbic acid 0.15%;

[0055] The balance was deionized water.

[0056] A method for preparing a simulated human body lubricating fluid comprises the following steps:

[0057] Add half the required amount of carboxymethyl cellulose to deionized water, raise the temperature to 30°C, slowly add hyaluronic acid into pure water while stirring at 1000 r / min until sodium hyaluronate is fully dissolved, then add core-shell liposomes, glycerol, squalane, vitamin E, chlorhexidine gluconate and sorbic acid, homogenize for 30 minutes, maintain the temperature, reduce the speed to 600 r / min, slowly add half the required amount of carboxymethyl cellulose, homogenize for 10 minutes, cool naturally to room temperature, and adjust the pH to 6.5-7.5 with a pH adjuster to obtain a simulated human body lubricating fluid.

[0058] The preparation steps of the core-shell liposome are as follows:

[0059] 1.5 mg of dipalmitoylphosphatidylcholine, 4.5 mg of distearoylphosphatidylcholine and 4 mg of cholesterol were dissolved in chloroform, and the organic solvent was evaporated under a constant nitrogen flow at 37°C to obtain a dry lipid film. An aqueous solution of tenofovir disoproxil fumarate was added at 65°C, and the mixture was centrifuged at 300 r / min for 30 min. The dispersion was sequentially extruded and filtered through 0.8 μm, 0.4 μm, 0.2 μm, and 0.1 μm polycarbonate membrane filters for 4 times each to obtain core-shell liposomes.

[0060] Example 2

[0061] A simulated human body lubricating fluid, comprising the following raw materials in percentage by mass:

[0062] Core-shell liposome 0.1%;

[0063] Glycerol 1%;

[0064] Hyaluronic acid 0.05%;

[0065] Carboxymethyl cellulose 8%;

[0066] Squalane 0.1%;

[0067] Sodium hydroxide 0.67%;

[0068] Vitamin E 0.01%;

[0069] Chlorhexidine gluconate 0.1%;

[0070] Sorbic acid 0.1%;

[0071] The balance was deionized water.

[0072] A method for preparing a simulated human body lubricating fluid comprises the following steps:

[0073] Add half the required amount of carboxymethyl cellulose to deionized water, raise the temperature to 30°C, slowly add hyaluronic acid into pure water while stirring at 1000 r / min until sodium hyaluronate is fully dissolved, then add core-shell liposomes, glycerol, squalane, vitamin E, chlorhexidine gluconate and sorbic acid, homogenize for 30 minutes, maintain the temperature, reduce the speed to 600 r / min, slowly add half the required amount of carboxymethyl cellulose, homogenize for 10 minutes, cool naturally to room temperature, and adjust the pH to 6.5-7.5 with a pH adjuster to obtain a simulated human body lubricating fluid.

[0074] The preparation steps of the core-shell liposome are as follows:

[0075] 1.5 mg of dipalmitoylphosphatidylcholine, 4.5 mg of distearoylphosphatidylcholine and 4 mg of cholesterol were dissolved in chloroform, and the organic solvent was evaporated under a constant nitrogen flow at 37°C to obtain a dry lipid film. An aqueous solution of tenofovir disoproxil fumarate was added at 65°C, and the mixture was centrifuged at 300 r / min for 30 min. The dispersion was sequentially extruded and filtered through 0.8 μm, 0.4 μm, 0.2 μm, and 0.1 μm polycarbonate membrane filters for 4 times each to obtain core-shell liposomes.

[0076] Example 3

[0077] A simulated human body lubricating fluid, comprising the following raw materials in percentage by mass:

[0078] Core-shell liposome 0.5%;

[0079] Glycerol 5%;

[0080] Hyaluronic acid 0.1%;

[0081] Carboxymethyl cellulose 12%;

[0082] Squalane 0.5%;

[0083] Sodium hydroxide 3%;

[0084] Vitamin E 0.05%;

[0085] Chlorhexidine gluconate 0.5%;

[0086] Sorbic acid 0.2%;

[0087] The balance was deionized water.

[0088] A method for preparing a simulated human body lubricating fluid comprises the following steps:

[0089] Add half the required amount of carboxymethyl cellulose to deionized water, raise the temperature to 30°C, slowly add hyaluronic acid into pure water while stirring at 1000 r / min until sodium hyaluronate is fully dissolved, then add core-shell liposomes, glycerol, squalane, vitamin E, chlorhexidine gluconate and sorbic acid, homogenize for 30 minutes, maintain the temperature, reduce the speed to 600 r / min, slowly add half the required amount of carboxymethyl cellulose, homogenize for 10 minutes, cool naturally to room temperature, and adjust the pH to 6.5-7.5 with a pH adjuster to obtain a simulated human body lubricating fluid.

[0090] The preparation steps of the core-shell liposome are as follows:

[0091] 1.5 mg of dipalmitoylphosphatidylcholine, 4.5 mg of distearoylphosphatidylcholine and 4 mg of cholesterol were dissolved in chloroform, and the organic solvent was evaporated under a constant nitrogen flow at 37°C to obtain a dry lipid film. An aqueous solution of tenofovir disoproxil fumarate was added at 65°C, and the mixture was centrifuged at 300 r / min for 30 min. The dispersion was sequentially extruded and filtered through 0.8 μm, 0.4 μm, 0.2 μm, and 0.1 μm polycarbonate membrane filters for 4 times each to obtain core-shell liposomes.

[0092] Comparative Example 1

[0093] A simulated human body lubricating fluid, comprising the following raw materials in percentage by mass:

[0094] Liposome 0.3%;

[0095] Glycerol 3%;

[0096] Hyaluronic acid 0.08%;

[0097] Carboxymethyl cellulose 10%;

[0098] Squalane 0.3%;

[0099] Sodium hydroxide 1.5%;

[0100] Vitamin E 0.03%;

[0101] Chlorhexidine gluconate 0.3%;

[0102] Sorbic acid 0.15%;

[0103] The balance was deionized water.

[0104] A method for preparing a simulated human body lubricating fluid comprises the following steps:

[0105] Add half the required amount of carboxymethyl cellulose to deionized water, raise the temperature to 30°C, slowly add hyaluronic acid into pure water while stirring at 1000 r / min until sodium hyaluronate is fully dissolved, then add liposomes, glycerol, squalane, vitamin E, chlorhexidine gluconate and sorbic acid, homogenize for 30 minutes, maintain the temperature, reduce the speed to 600 r / min, slowly add half the required amount of carboxymethyl cellulose, homogenize for 10 minutes, cool naturally to room temperature, and adjust the pH to 6.5-7.5 with a pH adjuster to obtain a simulated human body lubricating fluid.

[0106] The steps for preparing the liposome are as follows:

[0107] 6 mg of distearoylphosphatidylcholine and 4 mg of cholesterol were dissolved in chloroform, and the organic solvent was evaporated at 37°C under a constant nitrogen flow to obtain a dry lipid film. An aqueous solution was added at 65°C, and the mixture was centrifuged at 300 r / min for 30 min. The dispersion was sequentially extruded and filtered through 0.8 μm, 0.4 μm, 0.2 μm, and 0.1 μm polycarbonate membrane filters 4 times each to obtain liposomes.

[0108] The difference between this comparative example and Example 1 is that core-shell liposomes are not added, but conventional liposomes not loaded with tenofovir disoproxil fumarate are added.

[0109] Comparative Example 2

[0110] A simulated human body lubricating fluid, comprising the following raw materials in percentage by mass:

[0111] Distearoylphosphatidylcholine 0.3%;

[0112] Glycerol 3%;

[0113] Hyaluronic acid 0.08%;

[0114] Carboxymethyl cellulose 10%;

[0115] Squalane 0.3%;

[0116] Sodium hydroxide 1.5%;

[0117] Vitamin E 0.03%;

[0118] Chlorhexidine gluconate 0.3%;

[0119] Sorbic acid 0.15%;

[0120] The balance was deionized water.

[0121] A method for preparing a simulated human body lubricating fluid comprises the following steps:

[0122] Add half the required amount of carboxymethyl cellulose to deionized water, raise the temperature to 30°C, slowly add hyaluronic acid into pure water while stirring at 1000 r / min until sodium hyaluronate is fully dissolved, then add distearoyl phosphatidylcholine, glycerol, squalane, vitamin E, chlorhexidine gluconate and sorbic acid, homogenize for 30 minutes, maintain the temperature, reduce the speed to 600 r / min, slowly add half the required amount of carboxymethyl cellulose, homogenize for 10 minutes, cool naturally to room temperature, and adjust the pH to 6.5-7.5 with a pH adjuster to obtain a simulated human body lubricating fluid.

[0123] The difference between this comparative example and Example 1 is that core-shell liposomes are not added, but distearoylphosphatidylcholine, a raw material for preparing core-shell liposomes, is added.

[0124] Comparative Example 3

[0125] A simulated human body lubricating fluid, comprising the following raw materials in percentage by mass:

[0126] Cholesterol 0.3%;

[0127] Glycerol 3%;

[0128] Hyaluronic acid 0.08%;

[0129] Carboxymethyl cellulose 10%;

[0130] Squalane 0.3%;

[0131] Sodium hydroxide 1.5%;

[0132] Vitamin E 0.03%;

[0133] Sorbic acid 0.15%;

[0134] The balance was deionized water.

[0135] A method for preparing a simulated human body lubricating fluid comprises the following steps:

[0136] Add half the required amount of carboxymethyl cellulose to deionized water, raise the temperature to 30°C, slowly add hyaluronic acid into pure water while stirring at 1000 r / min until sodium hyaluronate is fully dissolved, then add cholesterol, glycerol, squalane, vitamin E, chlorhexidine gluconate and sorbic acid, homogenize for 30 minutes, maintain the temperature, reduce the speed to 600 r / min, slowly add half the required amount of carboxymethyl cellulose, homogenize for 10 minutes, cool naturally to room temperature, and adjust the pH to 6.5-7.5 with a pH adjuster to obtain a simulated human body lubricating fluid.

[0137] The difference between this comparative example and Example 1 is that core-shell liposomes and chlorhexidine gluconate are not added, but cholesterol, a raw material for preparing core-shell liposomes, is added.

[0138] test:

[0139] 1. Physical and chemical indicators

[0140] 1. Appearance

[0141] Take 25 mL of simulated human lubricating fluid into a colorimetric tube and observe visually at room temperature and without direct sunlight.

[0142] 2. Smell

[0143] At room temperature, sniff.

[0144] 3. pH value

[0145] The test was carried out according to the method of GB / T 9724. No solution preparation was required and samples were directly taken for testing.

[0146] 4. Viscosity

[0147] The test was carried out according to the third method of 0633 in Part 4 of the 2015 edition of the Chinese Pharmacopoeia, and the shear rate was 0.1s -1 , no need to prepare solution, just take sample for testing directly.

[0148] The test results are shown in Table 1.

[0149] 2. Microbiological Detection

[0150] Take 10g of the test sample and dilute it to a 1:10 test solution with sterile sodium chloride-protein buffer at pH 7.0. Stir for 1min to make it uniform. No need to adjust the pH. Take 1mL of the test solution and count Staphylococcus aureus and Escherichia coli according to the pouring method in 1105 of the 2015 edition of the Chinese Pharmacopoeia. The results should meet the requirements of 4.3.2.

[0151] The test results are shown in Table 2.

[0152] 3. Cumulative transmittance

[0153] 1. In vitro evaluation method

[0154] The in vitro transdermal absorption experiment was conducted using a Franz cell diffusion cell. The mouse abdominal skin was cut to remove hair and subcutaneous fat, blood vessels and other tissues, and then washed with physiological saline, and then fixed between a receiving cell coated with vaseline and a diffusion cell. 1% Tween-20 / physiological saline sustained-release solution was drawn with a syringe and filled into the receiving cell, and 1 mL of the simulated human lubricant of Examples 1-3 was taken and injected into the cell. The diffusion cell was then placed on a constant temperature water bath magnetic stirrer at 32°C ± 1°C and 300r / min. 1 mL was sampled at 1h, 2h, 4h, 6h, 8h, 12h, 24h, and 48h, and an equal amount of sustained-release solution was added at the same time. After adding Triton to the sample to break the emulsion, the volume was fixed to 5 mL, and then filtered into HPLC to analyze the concentration of tenofovir disoproxil fumarate, and the cumulative permeability P% was calculated. The calculation method is shown in the following formula.

[0155] P%=(C n ×V+∑ i i= = 1 n-1 C i ×V i ) / M×100%

[0156] C n —The concentration of tenofovir disoproxil fumarate measured at the nth sampling point (μg / mL)

[0157] C i —The concentration of tenofovir disoproxil fumarate measured at the i-th sampling point (μg / mL)

[0158] V i —The volume of the receiving solution taken out at the i-th point, 1 mL in this experiment;

[0159] V—total volume of the receiving pool, 15 mL in this experiment;

[0160] M—total mass of tenofovir disoproxil fumarate.

[0161] The results of the in vitro evaluation are shown in Table 3.

[0162] 4. Summary of experimental results and conclusions

[0163] Appearance odor pH Viscosity (MPa·s) Example 1 transparent Odorless 7.1 135 Example 2 transparent Odorless 6.7 133 Example 3 transparent Odorless 7.3 137 Comparative Example 1 transparent Odorless 6.8 179 Comparative Example 2 transparent Odorless 7.0 209 Comparative Example 3 transparent Odorless 7.1 213

[0164] Table 1

[0165]

[0166]

[0167] Table 2

[0168] 1h 2h 4h 6h 8h 12h 24h 48h Example 1 17.9 31.3 47.6 53.8 57.2 60.5 73.7 80.6 Example 2 20.1 33.6 46.3 52.9 56.5 59.4 72.8 80.1 Example 3 19.3 32.0 47.5 53.1 57.8 61.4 73.3 81.7

[0169] Table 3

[0170] It can be seen from Table 1 and Table 2 that the viscosity of Examples 1-3 is less than that of Comparative Examples 1-3, and the bactericidal performance of Examples 1-3 is better than that of Comparative Examples 1-3, indicating that the simulated human body lubricating fluid prepared by the present invention enhances the bactericidal and lubricating properties of the lubricating fluid. The preparation and addition of core-shell liposomes not only enables the lubricating fluid to combine the advantages of two lubrication mechanisms, but also, from the comparison between Comparative Examples 1-2 and Examples 1-3, it can be concluded that the core-shell liposomes also have certain bactericidal properties.

[0171] In the description of the specification, the description with reference to the terms "one embodiment", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.

[0172] The above contents are merely examples and explanations of the present invention. Those skilled in the art may make various modifications or additions to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the invention or exceed the scope defined by the claims, they shall all fall within the protection scope of the present invention.

Claims

1. A method for preparing a simulated human body lubricating fluid, characterized in that: The following raw materials are included in mass percentage: Core-shell liposome 0.05-0.5%; Penetration enhancer 0.8-5%; Hyaluronic acid 0.05-0.1%; Thickener 8-12%; Moisturizer 0.1-0.5%; pH adjuster 0.1-3%; Antioxidants 0.01-0.05%; Antibacterial agent 0.1-0.5%; Preservatives 0.05-0.25%; The balance is deionized water; The preparation method specifically comprises the following steps: Add half of the required amount of thickener to deionized water, raise the temperature to 25-35°C, slowly add hyaluronic acid into pure water while stirring at 800-1200r / min until sodium hyaluronate is fully dissolved, add core-shell liposomes, penetration enhancers, moisturizers, antioxidants, antibacterial agents and preservatives, homogenize for 30 minutes, maintain the temperature, reduce the speed to 300-600r / min, slowly add half of the required amount of thickener, homogenize for 10 minutes, cool naturally to room temperature, adjust the pH to 6.5-7.5 with a pH adjuster, and obtain a simulated human body lubricating fluid.

2. The method for preparing a simulated human body lubricating fluid according to claim 1, characterized in that: The preparation steps of the core-shell liposome are as follows: Dioleoylphosphatidylcholine, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine, distearoylphosphatidylcholine and cholesterol were dissolved in chloroform, and the organic solvent was evaporated under a constant nitrogen flow at 37°C to obtain a dry lipid film. An aqueous solution of tenofovir disoproxil fumarate was added at 45-65°C, and the mixture was centrifuged at 300 r / min for 30 min. The dispersion was sequentially extruded and filtered through 0.8 μm, 0.4 μm, 0.2 μm, and 0.1 μm polycarbonate membrane filters for 4 times each to obtain core-shell liposomes.

3. The method for preparing a simulated human body lubricating fluid according to claim 2, characterized in that: In the preparation step of the core-shell liposome, the dosage ratio of dioleoylphosphatidylcholine, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine, distearoylphosphatidylcholine, cholesterol and tenofovir disoproxil fumarate aqueous solution is (0-5.5) mg: (0-5.5) mg: (0-5.5) mg: (0-5.5) mg: (3-4) mg: 20 mL; the concentration of the tenofovir disoproxil fumarate aqueous solution is 40-120 μM / mL.

4. The method for preparing a simulated human body lubricating fluid according to claim 1, characterized in that: The penetration enhancer is one of propylene glycol, glycerol and polyethylene glycol.

5. The method for preparing a simulated human body lubricating fluid according to claim 1, characterized in that: The thickener is one of carboxymethyl cellulose, carboxyethyl cellulose and carboxypropyl cellulose.

6. The method for preparing a simulated human body lubricating fluid according to claim 1, characterized in that: The moisturizing agent is one or more of squalane, urea and vitamin B5.

7. The method for preparing a simulated human body lubricating fluid according to claim 1, characterized in that: The pH regulator is any one of hydrochloric acid, sulfuric acid, citric acid, sodium hydroxide, sodium bicarbonate, disodium hydrogen phosphate, and sodium dihydrogen phosphate; the pH of the simulated human body lubricating fluid is 6.5-7.

5.

8. The method for preparing a simulated human body lubricating fluid according to claim 1, characterized in that: The antioxidant is vitamin E; the antibacterial agent is chlorhexidine gluconate.

9. The method for preparing a simulated human body lubricating fluid according to claim 1, characterized in that: The preservative is one of sorbic acid, anisic acid and caprylhydroxamic acid.

10. Use of the simulated human body lubricant according to any one of claims 1 to 9 in low-, medium- and high-risk sexual behaviors without or with condoms between the same sex or the opposite sex.